Could molecular imaging transform prostate cancer management?

Recent results have shown that a novel PET/CT imaging technique combined with prostate-specific membrane antigen (PSMA) detection can more accurately detect prostate cancer progression compared with standard imaging techniques. Researchers hope that the molecular imaging technique will improve treatment decisions following initial diagnosis.A research team based at the Peter MacCallum Cancer Centre (Melbourne, Australia) have recently published the results of a randomized trial investigating the accuracy of a novel imaging method – PMSA-PET/CT – to detect disease progression and metastasis in prostate cancer. The study included 300 men and demonstrated that molecular imaging was 92% accurate, compared with 65% accuracy...